Explore more publications!

Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

Press releases published on October 14, 2025

TexStar Chiropractic Expands Leading Chiropractic Care in South Austin
Body by Ravi Plastic Surgery Launches RISE Med Spa in Houston, Welcoming Respected Nurse Injector Jamie Poole, RN
Phoenix Semiconductor Inks Distribution Partnership with Avnet
Silencing the Food Noise: Kristy McCammon Invites a Return to God’s Design for Food and Health
Globus Medical Launches ANTHEM™ Elbow Fracture System: A Comprehensive Plating Portfolio for Complex Elbow Trauma
EyePoint Announces Proposed Public Offering of Common Stock
PetMeds® Files Form 10-K for Fiscal 2025
WORK Medical Technology Group LTD Announces Receipt of Delisting Determination Letter from Nasdaq
Elutia to Present at the LD Micro Main Event XIX Conference on Tuesday, October 21
Century Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference
EyePoint Announces Pivotal Phase 3 Program Initiation for DURAVYU™ in Diabetic Macular Edema
Inventiva Announces the Implementation of a New ATM Program
Inventiva annonce la mise en place d’un nouveau programme « At-The-Market » (ATM)
Oral GLP-1 Tablets Gain Momentum as Telehealth Platform MEDVi Expands Access to Compounded Semaglutide and Tirzepatide for Physician-Supervised Weight Management
Op de AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics kondigt Merus de publicatie aan van het abstract over petosemtamab in gemetastaseerde colorectale kanker
Lung Cancer Antibody Drug Conjugates Market Size FDA Approved Lung Cancer ADC Clinical Trials Future Opportunity Insight
EmblemHealth Achieves 4-Star Medicare Rating, Highlighting Sustained Quality Improvements
Breakthrough in Obesity Solutions: Fuzzle’s Non-Invasive Oral Device Begins FDA Review Process
Lymphoma Antibody Drug Conjugates Treatment Market FDA Approved Drugs Clinical Trials Lymphoma ADC Market Opportunity Insight
CD40 Targeting Therapy Clinical Trials Anti CD40 Antibody Therapy Market Opportunity Assessment Insight

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions